Silence Therapeutics Plc Adr (SLN)

Dec 18, 2024

Top 3 Health Care Stocks That May Explode In Q4 - Benzinga

Dec 18, 2024

Dec 17, 2024

Silence Therapeutics' SWOT analysis: stock's potential in RNAi therapeutics - Investing.com

Dec 17, 2024

Dec 10, 2024

Silence Therapeutics' SWOT analysis: RNAi stock poised for growth amid clinical progress - Investing.com India

Dec 10, 2024

Dec 09, 2024

Silence Therapeutics announces additional results from SANRECO study - TipRanks

Dec 09, 2024

Nov 24, 2024

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels - MSN

Nov 24, 2024

Nov 20, 2024

GSK Drug for Rare Disease-Related Itch Meets Goal in Phase III Study - Yahoo Finance

Nov 20, 2024

Nov 20, 2024

United States shares mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com India

Nov 20, 2024

Nov 19, 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com

Nov 19, 2024

Nov 19, 2024

Silence Therapeutics weakness after AHA updates ‘overdone,’ says BMO Capital - TipRanks

Nov 19, 2024

Nov 19, 2024

SILENCE THERAPEUTICS PLC SPONSORED ADR trading resumes - TipRanks

Nov 19, 2024

Nov 19, 2024

Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga

Nov 19, 2024

Nov 17, 2024

Silence Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 17, 2024

Nov 14, 2024

Silence Therapeutics: Rising Assets Amid Growing Losses - TipRanks

Nov 14, 2024

Oct 21, 2024

Novartis Gets CHMP Recommendation for Kisqali in Broader Population - Yahoo Finance

Oct 21, 2024

Oct 16, 2024

80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - 新浪香港

Oct 16, 2024

Oct 01, 2024

ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty - Yahoo Finance

Oct 01, 2024

Sep 30, 2024

Silence Therapeutics's SWOT analysis: stock poised for growth in genetic medicine By Investing.com - Investing.com South Africa

Sep 30, 2024

Sep 30, 2024

Silence Therapeutics's SWOT analysis: stock poised for growth in genetic medicine - Investing.com

Sep 30, 2024

Sep 25, 2024

Biogen's Lupus Candidate Meets Key Goals in Phase III Study - Yahoo Finance

Sep 25, 2024

Sep 24, 2024

CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease - Yahoo Finance

Sep 24, 2024

Sep 02, 2024

It makes sense and dollars to buy Silence Therapeutics Plc ADR (SLN) stock - SETE News

Sep 02, 2024

Sep 02, 2024

Silence Therapeutics Plc ADR (SLN) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Sep 02, 2024

Sep 02, 2024

What Did We Find About Insider Trading At Silence Therapeutics Plc ADR (NASDAQ: SLN)? - Stocks Register

Sep 02, 2024

Sep 02, 2024

Silence Therapeutics shares start at Buy from Jefferies, reflecting strong clinical data - Investing.com UK

Sep 02, 2024

Aug 30, 2024

H.C. Wainwright reiterates Buy on Silence Therapeutics stock amid strong trial results By Investing.com - Investing.com South Africa

Aug 30, 2024

Aug 29, 2024

GSK's RSV Vaccine Arexvy Gets EU Nod for Adults Aged 50-59 Years - Yahoo Finance

Aug 29, 2024

Aug 15, 2024

How did Silence Therapeutics Plc ADR (SLN) fare last session? - US Post News

Aug 15, 2024

Aug 15, 2024

Ratio Revelations: Silence Therapeutics Plc ADR (SLN)’s Financial Metrics in the Spotlight - The Dwinnex

Aug 15, 2024

Aug 09, 2024

Silence Therapeutics Plc ADR (SLN) deserves closer scrutiny - US Post News

Aug 09, 2024

Aug 09, 2024

Market Insight: Silence Therapeutics Plc ADR (SLN)’s Notable Drop, Closing at 16.70 - The Dwinnex

Aug 09, 2024

Aug 07, 2024

The 3 Best Gene Editing Stocks to Buy in August 2024 - Markets Insider

Aug 07, 2024

Jul 25, 2024

It would be worthwhile to take a closer look at Silence Therapeutics Plc ADR (SLN) - US Post News

Jul 25, 2024

Jul 12, 2024

Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last? - Yahoo Finance

Jul 12, 2024

Jul 04, 2024

Silence Therapeutics Plc ADR (SLN) deserves closer scrutiny – US Post News - US Post News

Jul 04, 2024

Jun 28, 2024

Silence Therapeutics stock holds Buy rating on positive trial results By Investing.com - Investing.com India

Jun 28, 2024

Jun 26, 2024

Zacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics - Yahoo Lifestyle UK

Jun 26, 2024

Jun 25, 2024

Hardman & Co Insight: Survival of the UK life sciences sector - Research Tree

Jun 25, 2024

Jun 24, 2024

Cathie Wood's ARK ETF focuses on PagerDuty, 10X Genomics stock By Investing.com - Investing.com

Jun 24, 2024

Jun 21, 2024

Altria maintains stock target, Buy rating on FDA move By Investing.com - Investing.com UK

Jun 21, 2024

Jun 20, 2024

Zerlasiran shows promise in phase 2 study for cardiovascular risk By Investing.com - Investing.com

Jun 20, 2024

Jun 06, 2024

Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates - Yahoo Finance

Jun 06, 2024

Apr 29, 2024

Kirby Corp CEO sells shares worth over $360k By Investing.com - Investing.com

Apr 29, 2024

Apr 12, 2024

Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains? - Yahoo Finance

Apr 12, 2024

Feb 24, 2024

Silence Therapeutics: Multiple 2024 Catalysts Make This mRNA Biotech Worth A Look - Seeking Alpha

Feb 24, 2024

Feb 16, 2024

Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains? - Yahoo Finance

Feb 16, 2024

Dec 15, 2023

Here's Why Momentum in Silence Therapeutics PLC Sponsored ADR (SLN) Should Keep going - MSN

Dec 15, 2023

Dec 06, 2023

Does Silence Therapeutics PLC Sponsored ADR (SLN) Have the Potential to Rally 187.05% as Wall Street Analysts Expect? - Yahoo Finance

Dec 06, 2023

Nov 01, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 01, 2023

Feb 06, 2023

Silence Therapeutics Plc ADR (SLN-Q) QuotePress Release - The Globe and Mail

Feb 06, 2023

Oct 06, 2020

The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation - Yahoo Finance

Oct 06, 2020

Feb 26, 2014

Silence Therapeutics A Quieter Name In RNAi (NASDAQ:SLN) - Seeking Alpha

Feb 26, 2014

Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011